Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Dermatologic 1CNS 1

Conditions

Leukemia, Myeloid, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Leukemia 2Hematologic Neoplasms 2Wilms Tumor 1Sarcoma 1Melanoma 1Hepatic Veno-Occlusive Disease 1Hematologic Diseases 1Glioma 1Congenital Abnormalities 1

Interventions

Filgrastim 4Cyclophosphamide 4Psychiatric Rehabilitation 3Palliative Care 3Busulfan 3aflibercept 2Vincristine 2Thalidomide 2Radiotherapy 2Paclitaxel 2Melphalan 2Leucovorin 2Irinotecan 2Gemcitabine 2Etoposide 2Doxorubicin 2Docetaxel 2Celecoxib 2Azacitidine 2Analgesia 2venetoclax 1trimetrexate glucuronate 1tazemetostat 1tanespimycin 1sargramostim 1romidepsin 1ripretinib 1pembrolizumab 1liposomal doxorubicin 1ixabepilone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Genetic Testing × Other hematologic neoplasm × Clear all
NCT01772771 2026-03-03

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

M.D. Anderson Cancer Center

Recruiting
12,000 enrolled
CNSDermatologicOther hematologic neoplasmSarcoma

Glioma, Melanoma, Sarcoma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡